Investigating novel therapies at the bench to translate hope to bedside.
Started in 2021, the Howard Lab aims to increase the therapeutic ratio of conventional radiotherapy by utilizing therapeutic agents to sensitize tumors and protect normal tissues for improved clinical outcomes in pediatric brain cancer patients.
